Clinical Trials List
2021-08-01 - 2023-05-31
Phase III
Recruiting2
ICD-10D47.3
Essential (hemorrhagic) thrombocythemia
ICD-10D69.3
Immune thrombocytopenic purpura
ICD-10D69.41
Evans syndrome
ICD-10D69.42
Congenital and hereditary thrombocytopenia purpura
ICD-10D69.49
Other primary thrombocytopenia
ICD-9287.3
Primary thrombocytopenia
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yu-Sheng Chang 風濕免疫科
- Tsu-Yi Chao Division of Hematology & Oncology
- 林聖閎 風濕免疫科
- Wei-Hong Cheng Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSUAN JEN SHIH Division of Hematology & Oncology
- 王元欽 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
156 participants
